The Chinese Society for Immunology (CSI), a voluntary, national, academic, non-profit and non-governmental organization, formed from the national scientific and technical immunologists, is registered and established in accordance with the laws of China. CSI has grown out of the Chinese Committee for Immunology, which was founded in 1984, and became a member of the International Union of Immunological Societies (IUIS) in the same year. The formal proceedings to establish CSI began in 1988 after it was approved and affiliated with the China Association for Science and Technology. In 1992, CSI became a member of The Federation of Immunological Societies of Asia-Oceania (FIMSA). Currently, the society possesses over 10000 members and 3500 members belong to the IUIS.

Zhigang Tian, MD, PhD

Xuetao Cao, MD, PhD

Official Journal of CSI

International Meetings of Interest

The Keystone Symposia 2019 Innate Immunity Conference
(March 10 - 14, 2019, Taipei City, China)

17th International Congress of Immunology
(October 18 - 23, 2019, Beijing, China)


Prof. Di Wang’s group revealed a new mechanism of intermodulation between immune system and metabolism

Prof. Wanli Liu and Zhanguo Li published a Science paper reporting a novel mechanism on the regulation and activation of B lymphocytes in autoimmune diseases

Prof. Xuetao Cao’s Group sheds new insight into the origin of connective tissue-resident mast cells

Prof. Yonghui Zhang’s Group Revealed New Immune Regulation Mechanism of Mevalonate Pathway

13th CSI Annual Meeting

New FIMSA Council Elected

Chinese Scholars Unveil New Mechanisms Responsible for the Synergistic Effect of ICIs and Therapeutic Antibodies

Dr. Feng Shao’s laboratory discovered a novel anti-bacterial pattern recognition receptor

Prof. Erwei Song and Shicheng Su’s group revealed a new mechanism of tumor immune evasion regulated by an lncRNA

Summer School 2018 of CSI

Prof. Xing Chang’s Group Revealed New Pathogenic Mechanism of Autoimmune Disease

2nd CSI-BSI Joint Symposium on Immunology

Prof. Xin Lin’s group revealed the role of CARD9 mutation in regulating allergic bronchopulmonary aspergillosis (ABPA) pathogenesis

Prof. Xuetao Cao’s group discovered novel tumor-induced splenic erythroblast-like cells in cancer